Spots Global Cancer Trial Database for Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
Official Title: Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, at Six Month Follow-Up, and Long-Term Follow-Ups
Study ID: NCT01382082
Interventions
Study Description
Brief Summary: Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is needed on promising biomarkers and allelic variants that may help to determine the etiology of impairment, identify those most vulnerable to impairment, and develop interventions for these difficulties. This is a longitudinal observational study of cognitive function in breast cancer and lymphoma patients receiving chemotherapy to better understand the prevalence of cognitive difficulties (i.e., problems with memory, executive function, and attention) in these populations.
Detailed Description:
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Delaware/Christiana Care NCORP, Newark, Delaware, United States
Delaware/Christiana Care NCORP (CHRISTIANA), Newark, Delaware, United States
Heartland, Decatur, Illinois, United States
Kansas City Clinical Oncology Program, Prairie Village, Kansas, United States
Wichita NCORP, Wichita, Kansas, United States
Wichita, Wichita, Kansas, United States
Gulf South MU-NCORP, New Orleans, Louisiana, United States
Cancer Research Consortium of West Michigan, Grand Rapids, Michigan, United States
CRCWM, Grand Rapids, Michigan, United States
Metro Minnesota NCORP, Minneapolis, Minnesota, United States
Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States
CCOP - Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
Nevada, Las Vegas, Nevada, United States
Hem Onc CNY, East Syracuse, New York, United States
Kansas City, Rochester, New York, United States
University of Rochester Cancer Center, Rochester, New York, United States
Novant Health Cancer Institute - Kernersville, Winston-Salem, North Carolina, United States
Southeast Clinical Oncology Research Program, Winston-Salem, North Carolina, United States
Columbus NCORP, Columbus, Ohio, United States
Columbus, Columbus, Ohio, United States
Dayton Community Oncology Program, Dayton, Ohio, United States
Dayton, Dayton, Ohio, United States
Pacific Cancer Research Consortium Ncorp, Portland, Oregon, United States
PCRC, Portland, Oregon, United States
NCORP of the Carolinas, Greenville, South Carolina, United States
Upstate Carolina, Spartanburg, South Carolina, United States
Northwest (Virginia Mason), Seattle, Washington, United States
Wisconsin NCORP, Marshfield, Wisconsin, United States
Aurora NCORP, Milwaukee, Wisconsin, United States
Contact Details
Name: Michelle C. Janelsins, PhD
Affiliation: University of Rochester
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
